AM
DGX icon

AGF Management’s Quest Diagnostics DGX Stock Holding History

AGF Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3M Sell
15,592
-2,075
-12% -$407K 0.01% 330
2026
Q1 		$3.46M Buy
17,667
+1,517
+9% +$295K 0.02% 365
2025
Q4 		$2.8M Sell
16,150
-2,011
-11% -$366K 0.01% 439
2025
Q3 		$3.46M Buy
18,161
+185
+1% +$32.8K 0.02% 342
2025
Q2 		$3.23M Buy
17,976
+2,567
+17% +$446K 0.01% 319
2025
Q1 		$2.61M Sell
15,409
-603
-4% -$99.1K 0.01% 403
2024
Q4 		$2.42M Sell
16,012
-4,298
-21% -$668K 0.01% 427
2024
Q3 		$3.15M Buy
20,310
+3,395
+20% +$507K 0.02% 403
2024
Q2 		$2.32M Sell
16,915
-810
-5% -$111K 0.01% 419
2024
Q1 		$2.36M Buy
+17,725
New +$2.3M 0.01% 425
2023
Q3 		– Sell
-459,162
Closed -$64.5M – 734
2023
Q2 		$64.5M Buy
459,162
+2,286
+0.5% +$315K 0.47% 71
2023
Q1 		$64.6M Sell
456,876
-5,374
-1% -$769K 0.44% 77
2022
Q4 		$72.3M Buy
+462,250
New +$66.4M 0.52% 66

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

AGF Management's DGX Position: Q2 2026 in Review

AGF Management reduced its Quest Diagnostics (DGX) stake by 12% in Q2 2026, selling an estimated $407K and leaving 15,592 shares worth $3.3M. The position accounts for 0.01% of the portfolio, ranked #330.

AGF Management first reported a position in DGX in Q4 2022 and has held it in 13 quarters since. The position peaked at $72.3M in Q4 2022. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • AGF Management held 15,592 shares of Quest Diagnostics worth $3.3M as of Q2 2026.
  • AGF Management sold 2,075 Quest Diagnostics shares in Q2 2026, an estimated $407K.
  • Quest Diagnostics made up 0.01% of AGF Management's portfolio in Q2 2026, its #330 holding.
  • AGF Management first reported a position in Quest Diagnostics in Q4 2022 and has held it in 13 quarters since.
  • AGF Management's Quest Diagnostics position peaked at $72.3M in Q4 2022.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.